We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current AMPH market cap is 1.93B. The company's latest EPS is USD 2.8598 and P/E is 14.05.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 120.13M | 135.02M | 140.02M | 145.71M | 180.56M |
| Operating Income | 23.23M | 36.66M | 33.43M | 36.9M | 72.68M |
| Net Income | 15.87M | 33.91M | 26.03M | 26.12M | 49.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 322.36M | 349.85M | 437.77M | 498.99M | 644.4M |
| Operating Income | -39k | 10.95M | 69.68M | 106.32M | 196.99M |
| Net Income | 48.94M | 1.4M | 62.12M | 91.39M | 137.55M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 726.7M | 741.99M | 773.66M | 1.38B | 1.54B |
| Total Liabilities | 221.53M | 213.33M | 225.08M | 789.03M | 949.49M |
| Total Equity | 505.17M | 528.66M | 548.58M | 589.24M | 595.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 586.97M | 631.24M | 671.53M | 741.99M | 1.51B |
| Total Liabilities | 159.44M | 182.51M | 226.01M | 213.33M | 873.49M |
| Total Equity | 427.53M | 448.72M | 445.52M | 528.66M | 639.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 73.96M | 89.18M | 40.38M | 95.31M | 159.64M |
| Investing | -32.55M | -32.78M | -6.33M | -514.92M | -546.07M |
| Financing | -10.28M | -26.44M | -13.55M | 414.56M | 501.18M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 41.76M | 57.27M | 97.99M | 89.18M | 183.5M |
| Investing | -50.53M | -36.42M | -28.67M | -32.78M | -649.12M |
| Financing | -3.78M | -2.25M | -37.02M | -26.44M | 454.09M |
| Market Cap | 1.93B |
| Price to Earnings Ratio | 14.05 |
| Price to Sales Ratio | 3 |
| Price to Cash Ratio | 13.39 |
| Price to Book Ratio | 3.02 |
| Dividend Yield | - |
| Shares Outstanding | 48.1M |
| Average Volume (1 week) | 372.77k |
| Average Volume (1 Month) | 361.87k |
| 52 Week Change | -9.01% |
| 52 Week High | 67.66 |
| 52 Week Low | 35.62 |
| Spread (Intraday) | 5.55 (12.46%) |
| Company Name | Amphastar Pharmaceuticals Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.amphastar.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
